RxDoctor Payments Data

Samuel Rheinhardt, MD

Surgery · Saint Charles, MONPI 1174903488

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Intuitive Surgical at 58.6% of the total. Reporting peaked in 2023 at $24,932 and has fallen 58.5% since, to $10,358 in 2025. Among surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,970in general payments, 2019–2025

Across 195 payments — averaging $348.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$40K
  • Medtronic$23K
  • TELA Bio, Inc.$3K
  • Applied Medical Resources Corporation$1K
  • Aroa Biosurgery Incorporated$279
  • Johnson & Johnson$206
  • plus $193 from 3 others

What the payments were for

  • Consulting fees$9,82514%
  • Speaking & faculty fees$9,00013%
  • Travel & lodging$7,53611%
  • Food & beverage$8,59313%
  • Education$33,00049%
  • Gifts$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,970 in reported general payments places this provider in the 95th percentile of 612 surgery providers in Missouri.

See all surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$91,098
Medicare patients
122
Services billed
334

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf14$2,239
Metronidazole63$85
Ciprofloxacin Hcl61$83
Oxycodone Hcl22$46
Ondansetron Hcl41$42

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braintree Laboratories, Inc.Sutab$16$2,23914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 612 surgery providers in Missouri.

Other surgery in Saint Charles

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →